Cargando…

CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5–AP-1 axis

Abnormal expression of cyclin-dependent kinase 5 (CDK5) has been found in several human cancers, whereas the role of CDK5 in the malignant development of colorectal cancer (CRC) has not been well characterized. Here we investigated the role of CDK5 in CRC and found that its expression was much highe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Kangmin, Zhang, Juchang, Xiong, Man, Wang, Xianfei, Luo, Xiaobei, Han, Lu, Meng, Yan, Zhang, Yali, Liao, Wenting, Liu, Side
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133995/ https://www.ncbi.nlm.nih.gov/pubmed/27735944 http://dx.doi.org/10.1038/cddis.2016.333

Ejemplares similares

KIF20A promotes cellular malignant behavior and enhances resistance to chemotherapy in colorectal cancer through regulation of the JAK/STAT3 signaling pathway
por: Xiong, Man, et al.
Publicado: (2019)

An Erk/Cdk5 axis controls the diabetogenic actions of PPARγ
por: Banks, Alexander S., et al.
Publicado: (2014)

Comprehensive analysis of the prognosis and immune effect of the oncogenic protein Four Jointed Box 1
por: Huang, Mei, et al.
Publicado: (2023)

Lipopolysaccharide-induced inflammation in human peritoneal mesothelial cells is controlled by ERK1/2-CDK5-PPARγ axis
por: Li, Zukai, et al.
Publicado: (2021)

Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
por: Ding, Jian, et al.
Publicado: (2022)

CDK3, CDK5 and CDK8 Proteins as Prognostic and Potential Biomarkers in Colorectal Cancer Patients
por: Wang, Dan, et al.
Publicado: (2022)

MiR-452-5p promotes colorectal cancer progression by regulating an ERK/MAPK positive feedback loop
por: Lin, Xin, et al.
Publicado: (2021)

Ubiquitination of human AP-endonuclease 1 (APE1) enhanced by T233E substitution and by CDK5
por: Busso, Carlos S., et al.
Publicado: (2011)

Inhibition of CDK1 Reverses the Resistance of 5-Fu in Colorectal Cancer
por: Zhu, Yiping, et al.
Publicado: (2020)

Zinc induces CDK5 activation and neuronal death through CDK5-Tyr15 phosphorylation in ischemic stroke
por: Tuo, Qing-Zhang, et al.
Publicado: (2018)

Wnt5a/CaMKII/ERK/CCL2 axis is required for tumor-associated macrophages to promote colorectal cancer progression
por: Liu, Qing, et al.
Publicado: (2020)

Cdk3-promoted epithelial-mesenchymal transition through activating AP-1 is involved in colorectal cancer metastasis
por: Lu, Jinping, et al.
Publicado: (2016)

The ATF2/miR-3913-5p/CREB5 axis is involved in the cell proliferation and metastasis of colorectal cancer
por: Dai, Weiyu, et al.
Publicado: (2023)

Biological functions of CDK5 and potential CDK5 targeted clinical treatments
por: Shupp, Alison, et al.
Publicado: (2017)

TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal Carcinoma
por: Amin, Niranjana, et al.
Publicado: (2023)

MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells
por: Fukasawa, Kazuya, et al.
Publicado: (2023)

Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of Lipopolysaccharides
por: Shi, Xiaoyi, et al.
Publicado: (2020)

iTRAQ-Based Proteomics Screen identifies LIPOCALIN-2 (LCN-2) as a potential biomarker for colonic lateral-spreading tumors
por: Wang, Xianfei, et al.
Publicado: (2016)

TFP5-Mediated CDK5 Activity Inhibition Improves Diabetic Nephropathy via NGF/Sirt1 Regulating Axis
por: Cao, Shi-Lu, et al.
Publicado: (2022)

Lnc HAGLR Promotes Colon Cancer Progression Through Sponging miR‐185‐5p and Activating CDK4 and CDK6 in vitro and in vivo
por: Sun, Weixuan, et al.
Publicado: (2020)

Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis
por: Zheng, Ya-Li, et al.
Publicado: (2016)

5 New AP Structures
Publicado: (1984)

Clinicopathological Characteristics of Laterally Spreading Colorectal Tumor
por: Zhao, Xinhua, et al.
Publicado: (2014)

MCM3AP-AS1/miR-876-5p/WNT5A axis regulates the proliferation of prostate cancer cells
por: Wu, Jie, et al.
Publicado: (2020)

Hsa_circ_0006692 Promotes Lung Cancer Progression via miR-205-5p/CDK19 Axis
por: Liao, Jinrong, et al.
Publicado: (2022)

Cdk5 protects huntingtin
por: LeBrasseur, Nicole
Publicado: (2005)

Three decades of Cdk5
por: Pao, Ping-Chieh, et al.
Publicado: (2021)

Phosphorylation of ERK5 on Thr732 Is Associated with ERK5 Nuclear Localization and ERK5-Dependent Transcription
por: Honda, Takuto, et al.
Publicado: (2015)

CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis
por: Lai, Qiuhua, et al.
Publicado: (2020)

ERK MAP Kinase Activation in Spinal Cord Regulates Phosphorylation of Cdk5 at Serine 159 and Contributes to Peripheral Inflammation Induced Pain/Hypersensitivity
por: Zhang, Xiaoqin, et al.
Publicado: (2014)

CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathway
por: Bai, Xiaoyan, et al.
Publicado: (2016)

PCGF6/MAX/KDM5D facilitates MAZ/CDK4 axis expression and pRCC progression by hypomethylation of the DNA promoter
por: Zhu, Meng, et al.
Publicado: (2023)

The CDK5 repressor CDK5RAP1 is a methylthiotransferase acting on nuclear and mitochondrial RNA
por: Reiter, Veronika, et al.
Publicado: (2012)

Searching for Novel Cdk5 Substrates in Brain by Comparative Phosphoproteomics of Wild Type and Cdk5(−/−) Mice
por: Contreras-Vallejos, Erick, et al.
Publicado: (2014)

TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer
por: Zhang, Guolin, et al.
Publicado: (2022)

Curcumin Negatively Regulates Cigarette Smoke-Induced Renal Cell Carcinoma Epithelial–Mesenchymal Transition Through the ERK5/AP-1 Pathway
por: Zhang, Tao, et al.
Publicado: (2020)

PTPN18 promotes colorectal cancer progression by regulating the c-MYC-CDK4 axis
por: Li, Chao, et al.
Publicado: (2020)

Targeting the microRNA-21/AP1 axis by 5-fluorouracil and pirarubicin in human hepatocellular carcinoma
por: He, Xiaodong, et al.
Publicado: (2014)

Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma
por: AbuHammad, Shatha, et al.
Publicado: (2019)

Cdk5 deficiency and neurodegeneration in flies
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uup8tpes34pbd7ac67205kdg7a